Royce & Associates LP makes a new $407,000 investment in LeMaitre Vascular, Inc. (NASDAQ: LMAT)

0

Royce & Associates LP acquired a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) in Q1, according to its latest SEC filing. The fund acquired 8,757 shares of the medical device supplier’s stock, valued at around $407,000.

Several other large investors have also recently bought and sold shares of the company. Conestoga Capital Advisors LLC increased its stake in LeMaitre Vascular by 1.2% during the 1st quarter. Conestoga Capital Advisors LLC now owns 1,879,847 shares of the medical device supplier worth $87,357,000 after buying 22,663 additional shares last quarter. Copeland Capital Management LLC increased its stake in LeMaitre Vascular shares by 0.8% in the 1st quarter. Copeland Capital Management LLC now owns 1,215,005 shares of the medical device supplier worth $56,461,000 after buying 9,806 additional shares in the last quarter. Ranger Investment Management LP increased its equity stake in LeMaitre Vascular by 1.6% during the fourth quarter. Ranger Investment Management LP now owns 646,999 shares of the medical device supplier worth $32,499,000 after buying an additional 10,010 shares in the last quarter. Summit Creek Advisors LLC increased its equity stake in LeMaitre Vascular by 21.0% during the 4th quarter. Summit Creek Advisors LLC now owns 361,359 shares of the medical device supplier worth $18,151,000 after purchasing an additional 62,754 shares in the last quarter. Finally, Grandeur Peak Global Advisors LLC increased its stake in LeMaitre Vascular shares by 0.9% during the 4th quarter. Grandeur Peak Global Advisors LLC now owns 314,076 shares of the medical device supplier worth $15,776,000 after purchasing an additional 2,931 shares in the last quarter. 84.90% of the shares are currently held by hedge funds and other institutional investors.

Changes to analyst ratings

Separately, Barrington Research lowered its target price on LeMaitre Vascular from $54.00 to $50.00 in a Friday, April 29 report.

LeMaitre Vascular Stock Performance

LMAT opened at $53.24 on Friday. LeMaitre Vascular, Inc. has a one-year low of $38.32 and a one-year high of $60.79. The stock has a market capitalization of $1.17 billion, a PE ratio of 52.71, a P/E/G ratio of 4.66 and a beta of 1.20. The company’s 50-day moving average price is $46.43 and its 200-day moving average price is $45.13.

LeMaitre Vascular Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 8. Investors of record on Thursday, August 25 will receive a dividend of $0.125. This represents a dividend of $0.50 on an annualized basis and a yield of 0.94%. The ex-dividend date is Wednesday, August 24. LeMaitre Vascular’s dividend payout ratio is currently 49.51%.

LeMaitre Vascular Profile

(Get an assessment)

LeMaitre Vascular, Inc designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers an angioscope, a fiber optic catheter used to view the lumen of a blood vessel; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily block blood flow; infusion catheters for infusing blood and other fluids into the vascular system; and thrombectomy catheters, which feature a silicone balloon to remove thrombus in the venous system.

See also

Want to see which other hedge funds hold LMAT? Visit HoldingsChannel.com for the latest 13F filings and insider trading for LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating).

Institutional ownership by quarter for LeMaitre Vascular (NASDAQ:LMAT)



Get news and reviews for LeMaitre Vascular Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for LeMaitre Vascular and related companies with MarketBeat.com’s FREE daily email newsletter.

Share.

About Author

Comments are closed.